Skip to main content
SpringerLink
Log in

Clinical and Imaging Follow-Up After Transcatheter Aortic Valve Implantation

  • Chapter
Transcatheter Aortic Valve Implantation

  • 1365 Accesses

Abstract

Follow-up after transcatheter aortic valve implantation (TAVI) still varies from institution to institution, and efforts are being made to unify post-procedure care and monitoring. In the predominantly elderly population served by TAVI, careful attention to both clinical and imaging variables is important in guiding management and future therapies, in addition to preventing functional or clinical deterioration. This follow-up should begin immediately following valve implantation and continue at 1 month and yearly intervals, and as clinically indicated. This chapter will address the issues commonly encountered in the post-TAVI period, such as medication selection, electrical disturbances, and neurologic and functional status, and help guide their workup and management. In addition, it will review the cardiac parameters that are affected by valve replacement, including the prosthetic valve itself, and the methods by which to evaluate them.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Holmes DR, Nishmura RA, Grover FL, Brindis RG, Carroll JD, Edwards FH, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT Registry. J Am Coll Cardiol. 2015;66:2813–23.

    PubMed  Google Scholar 

  2. Kolte D, Khera S, Sardar R, Gheewala N, Gupta T, Chatterjee S, et al. Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights from the nationwide readmissions database. Circ Cardiovasc Interv. 2017;10:e004472. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004472.

    Article  PubMed  Google Scholar 

  3. Otto CM, Kumbhani DJ, Alexander KP, Calhoon JH, Desai MY, Kaul S, Lee JC, Ruiz CE, Vassileva CM. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis. J Am Coll Cardiol. 2017;69:1313–46.

    PubMed  Google Scholar 

  4. Nombela-Franco L, del Trigo M, Morrison-Polo G, Veiga G, Jimenez-Quevedo P, Altisent OA, et al. Incidence, causes, and predictors of early (≤ 30 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement. J Am Coll Cardiol Intv. 2015;8:1748–57.

    Google Scholar 

  5. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145:6–23.

    PubMed  Google Scholar 

  6. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatehter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    CAS  PubMed  Google Scholar 

  7. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    CAS  PubMed  Google Scholar 

  8. Popma JJ, Adams DH, Reardon MJ, Yakuboc SJ, Kleiman NS, Heimansohn D, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–81.

    PubMed  Google Scholar 

  9. Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015–24.

    CAS  PubMed  Google Scholar 

  10. Hansson NC, Grove EL, Andersen HR, Leipsic J, Mathiassen ON, Jensen JM, et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol. 2016;68:2059–69.

    PubMed  Google Scholar 

  11. Yanagisawa R, Hayashida K, Yamada Y, Tanaka M, Yashima F, Inohara T, et al. Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR. J Am Coll Cardiol Img. 2017;10:1–11.

    Google Scholar 

  12. Pache G, Schoechlin S, Blanke P, Dorfs S, Jander N, Arepalli CD, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J. 2016;37:2263–71.

    PubMed  Google Scholar 

  13. Vollema EM, Kong WKF, Katsanos S, Kamperidis V, van Rosendael PJ, ver der Kley F, et al. Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve hemodynamics, and stroke. Eur Heart J. 2017;38:1207–17.

    PubMed  Google Scholar 

  14. Holmes DR, Nishimura RA, Grover FL, Brindis RG, Carroll JD, Edwards FH, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. Ann Thorac Surg. 2016;101:789–800.

    PubMed  Google Scholar 

  15. Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Phillippon F, Rodes-Cabau J. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017;136:1049–69.

    PubMed  Google Scholar 

  16. Nazij TM, Dizon JM, Hahn RT, Babaliaros V, Douglas PS, El-Chami MF, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) Trial and Registry. J Am Coll Cardiol Intv. 2015;8:60–9.

    Google Scholar 

  17. Urena M, Webb JG, Tamburino C, Munoz-Garcia AJ, Cheema A, Dager AE, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014;129:1233–43.

    PubMed  Google Scholar 

  18. Amat-Santos IJ, Rodes-Cabau J, Urena M, DeLarochelliere R, Doyle D, Bagur R, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:178–88.

    CAS  PubMed  Google Scholar 

  19. Tarantini G, Mojoli M, Windecker S, Wendler O, Lefevre T, Saia F, et al. Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: An analysis from the SOURCE XT prospective multicenter registry. JACC Cardiovasc Interv. 2016;9:937–46.

    PubMed  Google Scholar 

  20. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.

    CAS  PubMed  Google Scholar 

  21. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. Surgical or transcatheter aortic valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31.

    PubMed  Google Scholar 

  22. Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870–8.

    PubMed  Google Scholar 

  23. Fairbairn TA, Mather AN, Bijsterveld P, Worthy G, Currie S, Goddard AJ, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98:18–23.

    PubMed  Google Scholar 

  24. Van Belle E, Hengstenberg C, Lefevre T, Kupatt C, Debry N, Husser O, et al. Cerebral embolism during transcatheter aortic valve replacement: the BRAVO-3 MRI study. J Am Coll Cardiol. 2016;68:589–99.

    PubMed  Google Scholar 

  25. Spaziano M, Francese D, Leon MB, Genereux P. Imaging and functional testing to assess clinical and subclinical neurological events after transcatheter or surgical aortic valve replacement: a comprehensive review. J Am Coll Cardiol. 2014;64:1950–63.

    PubMed  Google Scholar 

  26. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6:611–9.

    PubMed  Google Scholar 

  27. Zimpfer D, Czerny M, Kilo J, Kasimir MT, Madl C, Kramer L, et al. Cognitive deficit after aortic valve replacement. Ann Thorac Surg. 2002;75:407–12.

    Google Scholar 

  28. Zimpfer D, Kilo J, Czerny M, Kasimir MT, Madl C, Bauer E, et al. Neurocognitive deficit following aortic valve replacement with biological/mechanical prosthesis. Eur J Cardiothorac Surg. 2003;23:544–51.

    PubMed  Google Scholar 

  29. Auffret V, Campelo-Parada F, Regueiro A, del Trigo M, Chiche O, Chamandi C, et al. Serial changes in cognitive function following transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68:2129–41.

    PubMed  Google Scholar 

  30. Schwartz F, Bauman P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–10.

    Google Scholar 

  31. Sundt TM, Bailey MS, Moon MR, Mendeloff EN, Huddleston CB, Pasque MK, et al. Quality of life after aortic valve replacement at the age of >80 years. Circulation. 2000;102(Suppl 3):70–4.

    Google Scholar 

  32. Arnold SV, Spertus JA, Lei Y, Allen KB, Chhatriwalla AK, Leon MB, et al. Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis. Circ Heart Fail. 2013;6:61–7.

    PubMed  Google Scholar 

  33. Reynolds MR, Magnuson EA, Wang K, Thourani VH, Williams M, Zajarias A, et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscatheteER Valve) trial (Cohort A). J Am Coll Cardiol. 2012;60:548–58.

    PubMed  Google Scholar 

  34. Arnold SV, Reynolds MR, Wang K, Magnuson EA, Baron SJ, Chinnakondepalli KM, et al. Health status after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis at increased surgical risk: results from the CoreValve US Pivotal Trial. J Am Coll Cardiol Intv. 2015;8:1207–17.

    Google Scholar 

  35. Lange R, Beckmann A, Neumann T, Krane M, Deutsch MA, Landwehr S, et al. Quality of life after transcatheter aortic valve replacement: prospective data from GARY (German Aortic Valve Registry). J Am Coll Cardiol Intv. 2016;9:2541–54.

    Google Scholar 

  36. Arnold SV, Spertus JA, Vemulapalli S, Li Z, Matsouaka RA, Baron SJ, et al. Quality-of-life outcomes after transcatheter aortic valve replacement in an unselected population: a report from the STS/ACC transcatheter valve therapy registry. JAMA Cardiol. 2017;2:409–16.

    PubMed  PubMed Central  Google Scholar 

  37. Altisent OA, Puri R, Regueiro A, Chamandi C, Rodriguez-Gabella T, del Trigo M, et al. Predictors and association with clinical outcomes of the changes in exercise capacity after transcatheter aortic valve replacement. Circulation. 2017;136:632–43.

    Google Scholar 

  38. Pressler A, Christle JW, Lechner B, Grabs V, Haller B, Hettich I, et al. Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: a randomized pilot trial. Am Heart J. 2016;182:44–53.

    PubMed  Google Scholar 

  39. Arsalan M, Walther T. Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol. 2016;13:360–7.

    CAS  PubMed  Google Scholar 

  40. Rodriguez-Gabella T, Voisine P, Puri R, Pibarot P, Rodes-Cabau J. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol. 2017;70:1013–28.

    PubMed  Google Scholar 

  41. Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr. 2009;22:975–1014.

    PubMed  Google Scholar 

  42. Goel SS, Ige M, Tuzcu EM, Ellis SG, Stewart WJ, Svensson LG, et al. Severe aortic stenosis and coronary artery disease—implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol. 2013;62:1–10.

    PubMed  Google Scholar 

  43. Genereux P, Head SJ, Hahn R, Deneault B, Kodali S, Williams MR, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles’ heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013;61:1125–36.

    PubMed  Google Scholar 

  44. Sorajja P, Kodali S, Reardon MJ, Szeto WY, Chetcuti SJ, Hermiller J, et al. Outcomes for the commercial use of self-expanding prostheses in transcatheter aortic valve replacement: a report from the STS/ACC TVT Registry. J Am Coll Cardiol Intv. 2017;10:2090–8.

    Google Scholar 

  45. Thourani VH, Kodali S, Makkar RR, Hermann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25.

    PubMed  Google Scholar 

  46. Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchetche D, Manoharan G, et al. 1-Year outcomes with the fully repositionable and retrievable Lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: results of the REPRISE II study. J Am Coll Cardiol Intv. 2016;9:376–84.

    Google Scholar 

  47. Sinning JM, Vasa-Nicotera M, Chin D, Hammerstingl C, Ghanem A, Bence J, et al. Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;62:11–20.

    PubMed  Google Scholar 

  48. Pibarot P, Hahn RT, Weissman NJ, Monagham MJ. Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. J Am Coll Cardiol Img. 2015;8:340–60.

    Google Scholar 

  49. Ribeiro HB, Orwat S, Hayek SS, Larose E, Babaliaros V, Abdellaziz D, et al. Cardiovascular magnetic resonance to evaluate aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68:577–85.

    PubMed  Google Scholar 

  50. Rogers T, Waksman R. Role of CMR in TAVR. J Am Coll Cardiol Img. 2016;9:593–602.

    Google Scholar 

  51. Hartlage GR, Babaliaros VC, Thourani VH, Hayek S, Ghasemzadeh N, Stillman AE, et al. The role of cardiovascular magnetic resonance in stratifying paravalvular leak severity after transcatheter aortic valve replacement: an observational outcome study. J Cardiovasc Magn Reson. 2014;16:93–103.

    PubMed  PubMed Central  Google Scholar 

  52. Crouch G, Tully PJ, Bennetts J, Sinhal A, Bradbrook C, Penhall AL, et al. Quantitative assessment of paravalvular regurgitation following transcatheter aortic valve replacement. J Cardiovasc Magn Reson. 2015;17:32–7.

    PubMed  PubMed Central  Google Scholar 

  53. Leetmaa T, Hansson NC, Leipsic J, Jensen K, Poulsen SH, Andersen HR, et al. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast enhanced multidetector computed tomography. Circ Cardiovasc Interv. 2015;8:e001596. https://doi.org/10.1161/Circinterventiontions.114.001596.

    Article  PubMed  Google Scholar 

  54. Jose J, Sulimov DS, El-Mawardy M, Sato T, Allali A, Holy EW, et al. Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement: incidence, characteristics, and treatment outcomes. J Am Coll Cardiol Intv. 2017;10:686–97.

    Google Scholar 

  55. Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW, Councils of the American Association for Thoracic Surgery; Society of Thoracic Surgeons; European Association for Cardio-Thoracic Surgery; Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732–8.

    PubMed  Google Scholar 

  56. Del Trigo M, Munoz-Garcia AJ, Wijeysundera HC, Nombela-Franco L, Cheema AN, Gutierrez E, et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol. 2016;67:644–55.

    PubMed  Google Scholar 

  57. Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv. 2015;8:e001779. https://doi.org/10.1161/CircInterventions.114.001779.

    Article  PubMed  Google Scholar 

  58. De Marchena E, Mesa J, Pomenti S, Marin y Kall C, Marincic X, Yahagi K, et al. Thrombus formation following transcatheter aortic valve replacement. J Am Coll Cardiol Intv. 2015;8:728–39.

    Google Scholar 

  59. Chakravarty T, Sondergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389:2383–92.

    PubMed  Google Scholar 

  60. Egbe AC, Pislaru SV, Pellikka PA, Poterucha JT, Schaff HV, Maleszewski JJ, Connolly HM. Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol. 2015;66:2285–94.

    PubMed  Google Scholar 

  61. Holmes DR, Mack MJ. Aortic valve bioprostheses: leaflet immobility and valve thrombosis. Circulation. 2017;135:1749–56.

    PubMed  Google Scholar 

  62. Fraccaro C, Al-Lamee R, Tarantini G, Maisano F, Napodano M, Montorfano M, et al. Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: intermediate and mid-term results, a multicenter study. Circ Cardiovasc Interv. 2012;5:253–60.

    PubMed  Google Scholar 

  63. Clavel MA, Webb JG, Rodes-Cabau J, Masson JB, Dumont E, De Larochelliere R, et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation. 2010;122:1928–36.

    CAS  PubMed  Google Scholar 

  64. Schattke S, Baldenhofer G, Prauka I, Zhang K, Laule M, Stangl V, et al. Acute regional improvement of myocardial function after interventional transfemoral aortic valve replacement in aortic stenosis: a speckle tracking echocardiography study. Cardiovasc Ultrasound. 2012;10:15–22.

    PubMed  PubMed Central  Google Scholar 

  65. Giannini C, Petronio AS, Talini E, De Carlo M, Guarracino F, Delle Donne MG, et al. Early and late improvement of global and regional left ventricular function after transcatheter aortic valve implantation in patients with severe aortic stenosis: an echocardiographic study. Am J Cardiovasc Dis. 2011;1:264–73.

    PubMed  PubMed Central  Google Scholar 

  66. Nombela-Franco L, Eltchaninoff H, Zahn R, Testa L, Leon MB, Trillo-Nouche R, et al. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart. 2015;101:1395–405.

    CAS  PubMed  Google Scholar 

  67. Cortes C, Amat-Santos IJ, Nombela-Franco L, Munoz-Garcia AJ, Gutierrez-Ibanes E, De La Torre Hernandez JM, et al. Mitral regurgitation after transcatheter aortic valve replacement: prognosis, imaging predictors, and potential management. J Am Coll Cardiol Intv. 2016;9:1603–14.

    Google Scholar 

  68. Szymanski P, Hryniewiecki T, Dabrowski M, Sorysz KJ, Jastrzebski J, et al. Mitral and aortic regurgitation following transcatheter aortic valve replacement. Heart. 2016;102:701–6.

    CAS  PubMed  Google Scholar 

  69. Shibayama K, Harada K, Berdejo J, Mihara H, Tanaka J, Gurudevan SV, et al. Effect of transcatheter aortic valve replacement on the mitral valve apparatus and mitral regurgitation: real-time three-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2014;7:344–51.

    PubMed  Google Scholar 

  70. Barbanti M, Webb JG, Hahn RT, Feldman T, Boone RH, Smith CR, et al. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) trial cohort A. Circulation. 2013;128:2776–84.

    PubMed  Google Scholar 

  71. Kiramijyan S, Koifman E, Asch FM, Magalhaes MA, Didier R, Escarcega RO, et al. Impact of functional versus organic baseline mitral regurgitation on short- and long-term outcomes after transcatheter aortic valve replacement. Am J Cardiol. 2016;117:839–46.

    PubMed  Google Scholar 

  72. Medvedofsky D, Klempfner R, Fefer P, Chernomordik F, Hamdan A, Hay I, et al. The significance of pulmonary arterial hypertension pre- and post-transfemoral aortic valve implantation for severe aortic stenosis. J Cardiol. 2015;65:337–42.

    PubMed  Google Scholar 

  73. Testa L, Latib A, De Marco F, De Carlo M, Fiorina C, Montone R, et al. Persistence of severe pulmonary hypertension after transcatheter aortic valve replacement: incidence and prognostic impact. Cir Cardiovasc Interv. 2016;9:e003563. https://doi.org/10.1161/CircInterventions.115.003563.

    Article  Google Scholar 

  74. Masri A, Abdelkarim I, Sharbaugh MS, Althouse AD, Xu J, Han W, et al. Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement. Heart. 2018;104:821–7. https://doi.org/10.1136/heartjnl.2017.311978.

    Article  PubMed  Google Scholar 

  75. Sinning JM, Hammerstingl C, Chin D, Ghanem A, Schueler R, Sedaghat A, et al. Decrease of pulmonary hypertension impacts prognosis after transcatheter aortic valve replacement. EuroIntervention. 2014;9:1042–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VCU School of Medicine, VCU Pauley Heart Center, Richmond, VA, USA

    Barbara D. Lawson, Mohammed Quader, Luis A. Guzman & Zachary M. Gertz

Authors
  1. Barbara D. Lawson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed Quader
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis A. Guzman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zachary M. Gertz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luis A. Guzman .

Editor information

Editors and Affiliations

  1. Interventional Cardiology Unit, Pineta Grande Hospital, Castel Volturno, Caserta, Italy

    Arturo Giordano

  2. Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy

    Giuseppe Biondi-Zoccai  & Giacomo Frati  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Cite this chapter

Lawson, B.D., Quader, M., Guzman, L.A., Gertz, Z.M. (2019). Clinical and Imaging Follow-Up After Transcatheter Aortic Valve Implantation. In: Giordano, A., Biondi-Zoccai, G., Frati, G. (eds) Transcatheter Aortic Valve Implantation. Springer, Cham. https://doi.org/10.1007/978-3-030-05912-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-05912-5_12

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-05911-8

  • Online ISBN: 978-3-030-05912-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation